Vincristine and CYP3A5 Genetic Polymorphism in Rhabdomyosarcoma: Comment.

Daungsupawong, Hinpetch; Wiwanitkit, Viroj

Daungsupawong, Hinpetch; Wiwanitkit, Viroj.

Affiliation

Daungsupawong H; Private Academic Consultant, Phonhong, Lao People's Democratic Republic, Laos.
Wiwanitkit V; University Centre for Research and Development Department of Pharmaceutical Sciences, Chandigarh University Gharuan, Mohali, Punjab, India.

Asian Pac J Cancer Prev ; 25(6): 1861-1862, 2024 Jun 01.

Article in En | MEDLINE | ID: mdl-38918644

Subject(s)

Cytochrome P-450 CYP3A; Rhabdomyosarcoma; Vincristine; Humans; Cytochrome P-450 CYP3A/genetics; Rhabdomyosarcoma/genetics; Rhabdomyosarcoma/pathology; Vincristine/therapeutic use; Polymorphism, Genetic/genetics; Prognosis; Antineoplastic Agents, Phytogenic/therapeutic use

Key words

Chemotherapy; Genotype; cancer

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rhabdomyosarcoma / Vincristine / Cytochrome P-450 CYP3A Limits: Humans Language: En Journal: Asian Pac J Cancer Prev Journal subject: NEOPLASIAS Year: 2024 Document type: Article Affiliation country: LAOS

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google